1. Home
  2. CCRN vs ORKA Comparison

CCRN vs ORKA Comparison

Compare CCRN & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • ORKA
  • Stock Information
  • Founded
  • CCRN 1986
  • ORKA 2004
  • Country
  • CCRN United States
  • ORKA United States
  • Employees
  • CCRN N/A
  • ORKA N/A
  • Industry
  • CCRN Professional Services
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CCRN Consumer Discretionary
  • ORKA Health Care
  • Exchange
  • CCRN Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • CCRN 468.2M
  • ORKA 429.4M
  • IPO Year
  • CCRN N/A
  • ORKA N/A
  • Fundamental
  • Price
  • CCRN $14.26
  • ORKA $9.22
  • Analyst Decision
  • CCRN Buy
  • ORKA Strong Buy
  • Analyst Count
  • CCRN 4
  • ORKA 7
  • Target Price
  • CCRN $18.41
  • ORKA $39.67
  • AVG Volume (30 Days)
  • CCRN 322.4K
  • ORKA 382.5K
  • Earning Date
  • CCRN 04-30-2025
  • ORKA 05-15-2025
  • Dividend Yield
  • CCRN N/A
  • ORKA N/A
  • EPS Growth
  • CCRN N/A
  • ORKA N/A
  • EPS
  • CCRN N/A
  • ORKA N/A
  • Revenue
  • CCRN $1,344,004,000.00
  • ORKA N/A
  • Revenue This Year
  • CCRN N/A
  • ORKA N/A
  • Revenue Next Year
  • CCRN $4.96
  • ORKA N/A
  • P/E Ratio
  • CCRN N/A
  • ORKA N/A
  • Revenue Growth
  • CCRN N/A
  • ORKA N/A
  • 52 Week Low
  • CCRN $9.58
  • ORKA $5.49
  • 52 Week High
  • CCRN $18.50
  • ORKA $53.88
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 29.19
  • ORKA N/A
  • Support Level
  • CCRN $14.00
  • ORKA N/A
  • Resistance Level
  • CCRN $15.01
  • ORKA N/A
  • Average True Range (ATR)
  • CCRN 0.38
  • ORKA 0.00
  • MACD
  • CCRN 0.05
  • ORKA 0.00
  • Stochastic Oscillator
  • CCRN 20.00
  • ORKA 0.00

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: